MPG.eBooks - Search Results - "Parkinson"

Cover Image

1

Rotigotine (Neupro) (Transdermal patch)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Parkinson Disease / drug therapy...”

Cover Image

2

Rotigotine (Neupro) (Transdermal patch)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Parkinson Disease / drug therapy...”

Cover Image

3

Clinical review report: Apomorphine (Movapo) (Paladin Labs, Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Parkinson Disease / drug therapy...”

Cover Image

4

Deep brain stimulation for Parkinson's disease : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Lachance, Chantelle, Spry, Carolyn, MacDougall, Danielle
Published 2018

CADTH

Subjects: “...Parkinson Disease / therapy...”

Cover Image

5

Clinical review report: Levodopa/Carbidopa (Duodopa) (Abbvie Corporation)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Parkinson Disease / drug therapy...”

Cover Image

6

CADTH Canadian Drug Expert Committee recommendation: Levodopa/carbidopa intestinal gel (Duodopa -- Abbvie Corporation) : indication : Parkinson's disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Parkinson Disease / drug therapy...”

Cover Image

7

CADTH Canadian Drug Expert Committee recommendation: Levodopa/carbidopa intestinal gel (Duodopa -- Abbvie Corporation) : indication : Parkinson's disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Parkinson Disease / drug therapy...”

Cover Image

8

Pharmacoeconomic review report: Levodopa/Carbidopa (Duodopa) (Abbvie Corporation) : indication : for the treatment of patients with advanced levodopa-responsive Parkinson's disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Parkinson Disease / drug therapy...”

Cover Image

9

Pharmacoeconomic review report: Levodopa/Carbidopa (Duodopa) (Abbvie Corporation) : indication : for the treatment of patients with advanced levodopa-responsive Parkinson's disease

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Parkinson Disease / drug therapy...”

Cover Image

10

CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease

Published 2018

CADTH

Subjects: “...Parkinson Disease / drug therapy...”

Cover Image

11

CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease

Published 2018

CADTH

Subjects: “...Parkinson Disease / drug therapy...”

Cover Image

12

CADTH Canadian Drug Expert Committee recommendation: Safinamide (Onstryv -- Valeo Pharma Inc.) : indication: for add-on therapy to a regimen that includes levodopa for the treatmen...

Published 2020

CADTH

Subjects: “...Parkinson Disease / drug therapy...”

Cover Image

13

Clinical review report: Safinamide (Onstryv) (Valeo Pharma Inc.) : indication: for add-on therapy to a regimen that includes levodopa for the treatment of the signs and symptoms of...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Parkinson Disease / drug therapy...”

Cover Image

14

Pharmacoeconomic review report: Safinamide (Onstryv) (Valeo Pharma Inc.) : indication: for add-on therapy to a regimen that includes levodopa for the treatment of the signs and sym...

Published 2020

CADTH

Subjects: “...Parkinson Disease / drug therapy...”